America March 21, 2025
AstraZeneca invests $2.5B in China for R&D
In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…
America March 21, 2025
In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment…
By Rihem Akkouche
America March 20, 2025
Benson Hill Inc., a cutting-edge agricultural technology firm, has filed for Chapter 11 bankruptcy protection in Delaware federal court, citing…
By Rihem Akkouche
America March 4, 2025
Japanese regenerative medicine trailblazer Instinct Brothers Co. Ltd. announced Tuesday that it will go public via a merger with special…
By Rihem Akkouche
America February 26, 2025
In a high-stakes trade secrets battle, Pennsylvania-based biotech firm Renmatix Inc. suffered a major setback Monday when a Delaware vice…
By Rihem Akkouche
America February 24, 2025
Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…
By Rihem Akkouche
America May 25, 2024
Fox Rothschild LLP is bringing on a surgeon-turned-attorney with experience in patent advising within biotech, chemicals, and pharmaceuticals to its…
By Rochdi Rais
And More March 20, 2024
In a groundbreaking move for the life sciences industry, Clasp Therapeutics and Capstan Therapeutics unveiled separate funding initiatives totaling an…
By Rihem Akkouche
America March 7, 2024
In a strategic maneuver reminiscent of a high-stakes chess match, New York-based activist investor Caligan Partners LP has dramatically escalated…
By Rihem Akkouche
America February 5, 2024
Emeryville-based biotech firm, Metagenomi Inc., makes headlines as it dives into the IPO market, eyeing a substantial $100 million raise…
By Rochdi Rais
America December 12, 2023
In the wake of Changpeng “CZ” Zhao’s departure as the CEO of Binance, a new frontier may be on the…
By Jackie Allen